UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.13 +0.13 (+0.16%) GOLD FUTURES
2,330.20 +27.30 (+1.19%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,084.86 -1,922.23 (-4.00%)
Pharvaris N.V. (PHVS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 24.59 |
| Open | 24.04 |
| Bid | 23.57 x 100 |
| Ask | 25.23 x 100 |
| Day's range | 23.16 - 25.16 |
| 52-week range | 7.93 - 33.00 |
| Volume | |
| Avg. volume | 87,286 |
| Market cap | 1.322B |
| Beta (5Y monthly) | -3.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Zacks
Pharvaris (PHVS) Up as FDA Lifts Clinical Hold on HAE Program
Pharvaris (PHVS) rises 6% after the FDA lifts the clinical hold on the investigational candidate, deucrictibant, for the prophylactic treatment of HAE attacks.
- Simply Wall St.
Pharvaris N.V.'s (NASDAQ:PHVS) largest shareholders are private equity firms who were rewarded as market cap surged US$578m last week
Key Insights Significant control over Pharvaris by private equity firms implies that the general public has more power...
© 2024 Yahoo. All rights reserved.